C O M M U N I C A T I O N S
Scheme 2. Synthesis of (-)-Metazocinea
Acknowledgment. We thank the National Science Foundation
and the National Institute of Health, General Medical Sciences (GM-
13598), for their generous support of our programs. Mass spectra
were provided by the Mass Spectrometry Facility of the University
of California-San Francisco, supported by the NIH Division of
Research Resources. W.T. thanks Boehringer Ingelheim Pharma-
ceuticals, Inc. for a predoctoral fellowship
Supporting Information Available: Experimental details and
analytical data for all new compounds and data for synthetic benzo-
morphans (PDF). This material is available free for charge via the
References
(1) Novak, B. H.; Hudlicky, T.; Reed, J. W.; Mulzer, J.; Trauner, D. Curr.
Org. Chem. 2000, 4, 343; Hudlicky, T.; Butora, G.; Fearnley, S. P.; Gum,
A. G.; Stabile, M. R. Stud. Nat. Prod. Chem. 1996, 18, 43; Blakemore, P.
R.; White, J. D. Chem. Commun. 2002, 1159.
(2) Palmer, D. C.; Strauss, M. J. Chem. ReV. 1977, 77, 1.
(3) Kametani, T.; Kigasawa, K.; Hiiragi, M.; Wagatsuma, N. Heterocycles
1974, 2, 79; Clarke, E. G. C. Nature 1959, 184, 451.
(4) Neumeyer, J. L.; Bidlack, J. M.; Zong, R.; Bakthavachalam, V.; Gao, P.;
Cohen, D. J.; Negus, S. S.; Mello, N. K. J. Med. Chem. 2000, 43, 114;
Glick, S. D.; Visker, K. E.; Maisonneuve, I. M. Eur. J. Pharm. 1998,
357, 9.
(5) Tullar, B. F.; Harris, L. S.; Perry, R. L.; Pierson, A. K.; Soria, A. E.;
Wetterau, W. F.; Albertson, N. F. J. Med. Chem. 1967, 10, 383. It has
been reported that the inactive enantiomer has side effects: Berkowitz,
B. A. Eur. J. Pharm. 1974, 26, 359.
(6) Boulanger, W. A. Synth. Commun. 1999, 29, 2201; Brine, G. A.; Berrang,
B.; Hayes, J. P.; Carroll, F. I. J. Heterocycl. Chem. 1990, 27, 2139; Rice,
K. C.; Jacobson, A. E. J. Med. Chem. 1976, 19, 430.
(7) Comins, D. L.; Zhang, Y.-m.; Joseph, S. P. Org. Lett. 1999, 1, 657.
(8) Genisson, Y.; Marazano, C.; Das, B. C. J. Org. Chem. 1993, 58, 2052.
(9) Meyers, A. I.; Dickman, D. A.; Bailey, T. R. J. Am. Chem. Soc. 1985,
107, 7974.
(10) Grewe, R.; Mondon, A. Chem. Ber. 1948, 81, 279.
(11) A key intermediate for Grewe cyclization was prepared using catalytic
asymmetric hydrogenation of an enamide. Noyori, R.; Ohta, M.; Hsiao,
Y.; Kitamura, M.; Ohta, T.; Takaya, H. J. Am. Chem. Soc. 1986, 108,
7117; Kitamura, M.; Hsiao, Y.; Ohta, M.; Tsukamoto, M.; Ohta, T.;
Takaya, H.; Noyori, R. J. Org. Chem. 1994, 59, 297.
(12) Trost, B. M.; Tang, W. J. Am. Chem. Soc. 2002, 124, 14542.
(13) Molander, G. A.; Romero, J. A. C. Chem. ReV. 2002, 102, 2161; Seayad,
J.; Tillack, A.; Hartung, C. G.; Beller, M. AdV. Synth. Catal. 2002, 344,
795.
a Reaction conditions: a) CH2dPPh3, THF; b) 2% OsO4, NMO; c)
NaIO4; d) MeNH2, MgSO4, NaBH4; e) 1.5 equiv TsOH, toluene, reflux; f)
20 mol % BuLi, 20 mol % iPr2NH, THF, rt, 30 min; g) 20 mol % BuLi, 20
mol % iPr2NH, 40 mol % TMEDA, THF, rt, 8 h; h) BBr3, CH2Cl2.
of the medium by addition of 40 mol % TMEDA18 allowed reaction
of 15 and provided 17 more slowly (8 h) but still nearly
quantitatively. We hypothesized that the high diastereoselective
control of C-11 came from intramolecular protonation of the allylic
anion 18 from the alpha face (i.e., cis to the aminoethyl substituent
as depicted in 18′) of an almost flat six-membered ring. This is in
contrast to previous approaches employing Grewe cyclizations
which often gave both epimers.7,24 Finally, demethylation gave (-)-
metazocine (3), whose spectral data is identical to that previously
reported.7,9
To test the scope and selectivity of the migratory hydroamination,
amine 19 was prepared from 14 in a similar way (85% yield) and
treated with the catalyst system as for 15 (eq 2). Amine 20 was
obtained in quantitative yield as a single diastereomer. It is
noteworthy that the olefin of the prenyl substituent was unchanged.
Demethylation with NaSEt provided (-)-pentazocine (4)25 cleanly.
Thus, simply changing the amine in the reductive amination allows
easy variation of the N substituent.
(14) Carroll, F. I.; Bai, X.; Dehghani, A.; Mascarella, S. W.; Williams, W.;
Bowen, W. D. J. Med. Chem. 1999, 42, 4621.
(15) Sainsbury, M.; Williams, C. S.; Naylor, A.; Scopes, D. I. C. Tetrahedron
Lett. 1990, 31, 2763.
(16) For reviews see: Corey, E. J. Angew. Chem., Int. Ed. 1998, 388; Noyori,
R. Asymmetric Catalysis in Organic Synthesis; Wiley: New York, 1994;
The benzylic quaternary carbon center has been prepared by catalytic
asymmetric Heck reaction for the synthesis of a similar compound.
Takemoto, T.; Sodeoka, M.; Sasai, H.; Shibasaki, M. J. Am. Chem. Soc.
1993, 115, 8477.
(17) Trost, B. M.; Schroeder, G. M.; Kristensen, J. Angew. Chem., Int. Ed.
2002, 41, 3492; Trost, B. M.; Schroeder, G. M. J. Am. Chem. Soc. 1999,
121, 6759.
(18) Hartung, C. G.; Breindl, C.; Tillack, A.; Beller, M. Tetrahedron 2000,
56, 5157.
In conclusion, we have developed a highly efficient general
strategy for the enantioselective synthesis of benzomorphans (46%
and 45% overall yield from commercially available material for
(-)-metazocine and (-)-pentazocine, respectively). It demonstrates
for the first time the efficacy of palladium-catalyzed AAA of simple
ketones in the context of complex synthesis. The unprecedented
diastereoselective migratory hydroamination addresses the control
of C-11 stereogenic center, and should have many applications in
alkaloid synthesis. The strategy outlined here opens the way to
access either enantiomer26 of a variety of C-6, C-11, and N-3
substituted benzomorphan analogues.
(19) Trost, B. M.; Van Vranken, D. L. Chem. ReV. 1996, 96, 395.
(20) Prepared in one step (83% yield) from commercially available 7-methoxy-
2-tetralone. Kuehne, M. E. J. Am. Chem. Soc. 1961, 83, 1492.
(21) Sodium carbonate or potassium carbonate gave lower yield and ee.
(22) Tokuda, M.; Fujita, H.; Miyamoto, T.; Suginome, H. Tetrahedron 1993,
49, 2413.
(23) The relative stereochemistry was determined by NOE (see Supporting
Information).
(24) May, E. L.; Ager, J. H. J. Org. Chem. 1959, 24, 1432.
(25) Kametani, T.; Kigasawa, K.; Hiiragi, M.; Hayasaka, T.; Wagatsuma, N.;
Wakisaka, K. J. Heterocycl. Chem. 1969, 6, 43.
(26) Ligand ent-12 is also readily available. Trost, B. M.; Van Vranken, D.
L.; Bingel, C. J. Am. Chem. Soc. 1992, 114, 9327.
JA0360539
9
J. AM. CHEM. SOC. VOL. 125, NO. 29, 2003 8745